Leonardo, Narcisa T.

HRN: 28-64-55  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/05/2026
CIPROFLOXACIN 2MG/ML, 100ML IV
03/05/2026
03/11/2026
IV
500mg
Q12
Cholelithiasis
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: